XML 208 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue from External Customer [Line Items]        
Revenue $ 501,693 $ 429,485 $ 987,723 $ 931,554
Vimizim | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 171,655 116,695 329,953 253,898
Naglazyme | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 118,813 81,006 226,149 195,262
Kuvan | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 78,807 122,611 149,570 244,611
Palynziq | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 58,935 40,630 112,973 75,262
Brineura | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 30,332 25,798 57,657 49,768
Firdapse | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 0 0 0 1,316
Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | Marketed by Company        
Revenue from External Customer [Line Items]        
Revenue 458,542 386,740 876,302 820,117
Aldurazyme | Marketed by Genzyme        
Revenue from External Customer [Line Items]        
Revenue 28,128 32,292 78,137 87,958
Total net product revenues        
Revenue from External Customer [Line Items]        
Revenue $ 486,670 $ 419,032 $ 954,439 $ 908,075